Marketed By
celon
Pack of
28 Capsules In Bottle
Salt Composition
Sunitinib
Storage
Keep in Cold Place
Contact for Price
Sugistran 50mg Capsule
Delivering To: —
All Substitutes
Overview
Sugistran 50mg Capsule is an anticancer medicine with active ingredient Sunitinib. It is prescribed to certain types of kidney cancer, gastrointestinal stromal tumor, pancreatic neuroendocrine tumors, and medullary thyroid cancer. It works by blocking the action of specific enzyme. It effectively controls the progression of cancer, especially in the advance stages of cancer. It may take few weeks to few months to see the results so don't stop taking medicine on your own without informing your doctor.
Indication
Kidney Cancer, Gastrointestinal stromal tumors
Uses
- Renal cell carcinoma (RCC)
- Gastrointestinal stromal tumors (GIST)
- Pancreatic neuroendocrine tumors (PNET)
- Medullary thyroid cancer
- Certain kidney cancer
side effects
Like other anticancer medicines, Sugistran 50mg Capsule also has some common to severe side effects. These undesired symptoms observed in the body after taking this medicine and usually disappear with time as the body adjusts to the medicine.
Common Side Effects Include:
- Decreased appetite
- Mucositis
- High blood pressure
- Hand-foot syndrome
- Bleeding disorder
- Taste change
- Nausea
- Vomiting
- Weakness
- Fatigue
- Diarrhea
Above mentioned effects don't need any special medical attention, but if you observe them continually, talk to your doctor immediately.
How to use
The recommended dose Sugistran 50mg Capsule may vary according to the type & stage of cancer, or age, weight, and other health factors of the patients. This capsule should be swallowed as a whole with water and do not crush, chew, or open it. It is usually taken once a day, with or without food, at a fixed time each day. Don't miss a dose or double the dose to compensate for the missed dose.
How it works
Sugistran 50mg Capsule is an anticancer medicine with active ingredient Sunitinib that works by blocking the action of specific proteins known as tyrosine kinases. As this protein helps in signaling pathways that control growth and multiplication of cells. Thereby it effectively controls the progression of cancer, especially in the advance stages of cancer.
Safety Advice
Alcohol
UNSAFE
Pregnancy
CONSULT YOUR DOCTOR
Breastfeeding
CONSULT YOUR DOCTOR
Driving
DANGER
Kidney
PRECAUTION
Liver
PRECAUTION
FAQs
Sugistran 50mg is a prescription based anticancer medicine used in the treatment of kidney cancer, gastrointestinal stromal tumor, pancreatic neuroendocrine tumors, and medullary thyroid cancer.
Take Sugistran 50mg Capsule exactly as prescribed by the doctor at the same time each day.
It is advice to avoid the consumption of Sugistran 50mg in case of kidney or liver related issues.
It contains Sunitinib as an active ingredient that works by blocking the action of specific enzyme responsible for the growth of cancer cells.
There are some possible side effects of taking Sugistran 50mg such as taste change, nausea, vomiting, weakness, fatigue, diarrhea, etc.
References
- Motzer, R. J., Rini, B. I., Bukowski, R. M., Curti, B. D., George, D. J., Hudes, G. R., ... & Michaelson, M. D. (2006). Sunitinib in patients with metastatic renal cell carcinoma. Jama, 295(21), 2516-2524. https://pubmed.ncbi.nlm.nih.gov/16757724/
- Kelleher, F. C., & McDermott, R. (2008). Response to sunitinib in medullary thyroid cancer. Annals of internal medicine, 148(7), 567. https://pubmed.ncbi.nlm.nih.gov/18378960/
- Raymond, E., Hammel, P., Dreyer, C., Maatescu, C., Hentic, O., Ruszniewski, P., & Faivre, S. (2012). Sunitinib in pancreatic neuroendocrine tumors. Targeted oncology, 7(2), 117-125. https://pubmed.ncbi.nlm.nih.gov/22661319/
- Gan, H. K., Seruga, B., & Knox, J. J. (2009). Sunitinib in solid tumors. Expert opinion on investigational drugs, 18(6), 821-834. https://pubmed.ncbi.nlm.nih.gov/19453268/
- Motzer, R. J., Rini, B. I., Bukowski, R. M., Curti, B. D., George, D. J., Hudes, G. R., ... & Michaelson, M. D. (2006). Sunitinib in patients with metastatic renal cell carcinoma. Jama, 295(21), 2516-2524. https://pubmed.ncbi.nlm.nih.gov/16757724/
- Hiles, J. J., & Kolesar, J. M. (2008). Role of sunitinib and sorafenib in the treatment of metastatic renal cell carcinoma. American journal of health-system pharmacy, 65(2), 123-131. https://pubmed.ncbi.nlm.nih.gov/18192256/
- Hopkins, T. G., Marples, M., & Stark, D. (2008). Sunitinib in the management of gastrointestinal stromal tumours (GISTs). European Journal of Surgical Oncology (EJSO), 34(8), 844-850. https://www.researchgate.net/publication/5766997_Sunitinib_in_the_management_of_gastrointestinal_stromal_tumors_GISTs
Ratings And Reviews
4.50/5
4 Ratings
5 Star
75.00%
4 Star
0.00%
3 Star
25.00%
2 Star
0.00%
1 Star
0.00%
Suresh Bansal
Quality is outstanding
a year ago
David Martin
Fast delivery and great product
a year ago
View All Reviews
Related Products
MARKETER DETAILS
celon
DISCLAIMER
The contents of this website are for informative purposes only. They are not deliberated to be an alternative to any professional medical prescription and treatment. Seek the advice of a qualified health provider for questions regarding the medical condition. Do not ignore any professional medical advice because of something you have read on this website. This website offers links to other websites, thereby enabling you to go to the other website directly. Therefore, Magicine Pharma isn't responsible for the content of the links in the website or links in the linked websites. The links are provided to assist the visitors and are not approved by any professional health provider.